First Course and Debate on Controversies in Infertility, Istanbul, 4/2010

This international meeting on reproductive medicine took place in Istanbul. It reviewed and discussed all the contested topics in reproductive medicine, alongside new and future developments.

Invited lectures:

Low ovarian reserve: There are still some better protocols

Can women who produce a low number of oocytes after stimulation for IVF be helped? Reproductive medicine has many subjects of debate; the management of poor ovarian response is one of the most prominent. Many — more or less complex — treatment regimens have been proposed, but no universally accepted approach has yet emerged in the scientific community. The only intervention with evidence supporting an increase in the chance of pregnancy is the administration of growth hormone during ovarian stimulation.

Optimization of antagonist cycles

A presentation of the latest data on antagonist-based ovarian stimulation, drawing on a decade of accumulated experience since their introduction into clinical practice. There is no doubt that ovarian stimulation is moving in the direction of simpler, more patient-friendly regimens. Long-standing practices such as agonist administration — which entails much longer treatment and a higher incidence of OHSS — are slowly but steadily being abandoned. Antagonists today deliver pregnancies more simply and with greater safety.